Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPLE: Stepwise Lispro Mix 50/50 in Type 2 Diabetes
NCT00971997Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2009
- Primary completion
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin lispro + insulin lispro protamine in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Sep 2009; status: completed.
02
Drugs
insulin lispro + insulin lispro protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00971997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00971997.